05/09/2024
3:46 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:09 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:26 PM | Ironwood Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:28 PM | Ironwood Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:31 PM | Ironwood Pharmaceuticals (Filer)
| Form ARS | |
02/16/2024
6:01 AM | Ironwood Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:04 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/14/2024
8:01 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:50 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:53 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:35 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:39 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:42 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
2:12 PM | Ironwood Pharmaceuticals (Subject)
LSV ASSET MANAGEMENT (Filed by)
| Form SC 13G/A | |
01/25/2024
8:21 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
3:05 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:16 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
5:05 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:26 PM | Ironwood Pharmaceuticals (Subject)
Kessler Marla L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:07 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:30 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K/A | |
08/16/2023
3:20 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:21 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
3:02 PM | Ironwood Pharmaceuticals (Subject)
John Minardo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:08 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
4:36 PM | Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023
3:21 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC 13D | |
07/05/2023
11:01 AM | Ironwood Pharmaceuticals (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
06/29/2023
7:32 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/26/2023
3:08 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/22/2023
4:26 PM | Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:26 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:27 PM | Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:28 PM | Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:29 PM | Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:29 PM | Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
06/22/2023
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:31 PM | Ironwood Pharmaceuticals (Issuer)
Shepard Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:08 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:30 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/16/2023
6:09 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/07/2023
5:08 PM | Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
4:45 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
5:46 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T | |
05/24/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
3:05 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:26 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-C | |
05/22/2023
3:25 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
4:39 PM | Ironwood Pharmaceuticals (Subject)
MCCOURT Thomas A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
4:25 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
